XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows
$ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Cash flows used in operating activities:    
Net income $ 14,207 $ 8,903
Adjustments to reconcile net income to net cash flows used in operating activities    
Provision for credit losses on accounts receivable 540 54
Reserve for product returns 1,151 798
Recovery of credit losses on notes receivable 0 (78)
Amortization on patents and tooling 316 353
Amortization and depreciation 7,673 7,761
Amortization of debt issuance costs 784 780
Amortization of operating leases 2,750 2,473
Deferred income taxes (26,895) (10,650)
Change in fair value of contingent liability 13 0
Stock-based compensation 12,686 12,110
Changes in operating assets and liabilities (net of business acquisitions):    
Accounts receivable (1,843) 1,629
Inventory 377 (11,161)
Other current and non-current assets (689) (3,225)
Accounts payable, accrued expenses and other current liabilities (9,617) (21,450)
Deferred revenue 1,899 782
Operating lease liabilities (3,362) (2,975)
Other liabilities (3,511) (65)
Cash flows used in operating activities (3,521) (13,961)
Cash flows used in investing activities:    
Business acquisition, net of cash acquired (9,696) 0
Additions to property and equipment (2,398) (2,171)
Issuances of notes receivable (300) 0
Receipt of payments on notes receivable 13 16
Capitalized software development costs (362) 0
Purchase of investment in unconsolidated entity (200) 0
Cash flows used in investing activities (12,943) (2,155)
Cash flows from / (used in) financing activities:    
Purchases of treasury stock 0 (23,331)
Payments of acquired debt (469) 0
Issuances of common stock from equity-based plans 1,311 1,080
Cash flows from / (used in) financing activities 842 (22,251)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 13 0
Net decrease in cash, cash equivalents and restricted cash (15,609) (38,367)
Cash, cash equivalents and restricted cash at beginning of the period 622,879 710,621
Cash, cash equivalents and restricted cash at end of the period 607,270 672,254
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 606,428 671,753
Restricted cash included in other current assets and other assets 842 501
Total cash, cash equivalents and restricted cash $ 607,270 $ 672,254